An asymmetric tetrabody is a potent and efficacious agonist of the erythropoietin receptor in vitro and in vivo.

Saved in:
Bibliographic Details
Title: An asymmetric tetrabody is a potent and efficacious agonist of the erythropoietin receptor in vitro and in vivo.
Authors: Adams JJ; Anvil Institute for Systems Biologics, Canada.; Simisco Biosciences, USA., Blazer LL; Anvil Institute for Systems Biologics, Canada., Chung J; Anvil Institute for Systems Biologics, Canada.; EPOK Therapeutics, Canada., Karimi M; Université de Montréal, Canada., Davidson T; University of Texas Southwestern Medical Center, USA., Bruce HA; Anvil Institute for Systems Biologics, Canada., Singer AU; Anvil Institute for Systems Biologics, Canada., Yang N; Anvil Institute for Systems Biologics, Canada., Cardarelli L; Anvil Institute for Systems Biologics, Canada., Pot I; Anvil Institute for Systems Biologics, Canada., Colombo L; EPOK Therapeutics, Canada., Huang LJ; University of Texas Southwestern Medical Center, USA., Ma Y; University of Texas Southwestern Medical Center, USA., Michnick SW; Université de Montréal, Canada., Moe OW; EPOK Therapeutics, Canada.; University of Texas Southwestern Medical Center, USA., Sidhu SS; Anvil Institute for Systems Biologics, Canada.; Simisco Biosciences, USA.; EPOK Therapeutics, Canada.
Source: Protein science : a publication of the Protein Society [Protein Sci] 2025 Oct; Vol. 34 (10), pp. e70292.
Publication Type: Journal Article
Journal Info: Publisher: Cold Spring Harbor Laboratory Press Country of Publication: United States NLM ID: 9211750 Publication Model: Print Cited Medium: Internet ISSN: 1469-896X (Electronic) Linking ISSN: 09618368 NLM ISO Abbreviation: Protein Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1469-896X
DOI:10.1002/pro.70292